Alcoholic Ketoacidosis

Back

Background

In 1940, Dillon and colleagues first described alcoholic ketoacidosis (AKA) as a distinct syndrome. AKA is characterized by metabolic acidosis with an elevated anion gap, elevated serum ketone levels, and a normal or low glucose concentration.[1, 2]

Although AKA most commonly occurs in adults with alcoholism, it has been reported in less-experienced drinkers of all ages. Patients typically have a recent history of binge drinking, little or no food intake, and persistent vomiting.[3, 4, 5] A concomitant metabolic alkalosis is common, secondary to vomiting and volume depletion (see Workup).[6, 7]

Treatment of AKA is directed toward reversing the 3 major pathophysiologic causes of the syndrome, which are:

This goal can usually be achieved through the administration of dextrose and saline solutions (see Treatment).

Pathophysiology

The pathogenesis of AKA is complex.[8] Although the general physiological factors and mechanisms leading to AKA are understood, the precise factors have not been fully elucidated. The following are the 3 main predisposing events:

During starvation there is decrease in insulin secretion and increases in production of counter-regulatory hormones such as glucagon, catecholamines, cortisol, and growth hormone. Hormone-sensitive lipase is normally inhibited by insulin, and, when insulin levels fall, lipolysis is up-regulated, causing release of free fatty acids from peripheral adipose tissue.

Free fatty acids are either oxidized to CO2 or ketone bodies (acetoacetate, hydroxybutyrate, and acetone), or they are esterified to triacylglycerol and phospholipid. Carnitine acyltransferase (CAT) transports free fatty acids into the mitochondria and therefore regulates their entry into the oxidative pathway. The decreased insulin-to-glucagon ratio that occurs in starvation indirectly reduces the inhibition on CAT activity, thereby allowing more free fatty acids to undergo oxidation and ketone body formation.

Prolonged vomiting leads to dehydration, which decreases renal perfusion, thereby limiting urinary excretion of ketoacids. Moreover, volume depletion increases the concentration of counter-regulatory hormones, further stimulating lipolysis and ketogenesis.

Metabolism of ethanol

The metabolism of alcohol itself is a probable contributor to the ketotic state. Alcohol dehydrogenase (ADH), a cytosolic enzyme, metabolizes alcohol to acetaldehyde in hepatocytes. Acetaldehyde is metabolized further to acetic acid by aldehyde dehydrogenase. This reaction takes place within the mitochondria. Both steps require the reduction of nicotinamide adenine dinucleotide (NAD+) to reduced nicotinamide adenine dinucleotide (NADH). Thus, NAD+ is consumed and NADH is generated.

The resulting increase in the NADH/NAD+ ratio inhibits hepatic gluconeogenesis and elevates the ratio of hydroxybutyric acid to acetoacetic acid. Acetic acid (an acyl group carrier) is linked with coenzyme A (a thiol) to produce Acetyl-CoA. This process is catalyzed by the enzyme acetyl-CoA synthetase.

The decreased ratio of NAD+ to NADH has the following implications:

In contrast to diabetic ketoacidosis, the predominant ketone body in AKA is β-OH. Routine clinical assays for ketonemia test for AcAc and acetone but not for β-OH. Clinicians underestimate the degree of ketonemia if they rely solely on the results of laboratory testing.

Dehydration

All patients with severe AKA are dehydrated. Several mechanisms are responsible for dehydration, including protracted vomiting, decreased fluid intake, and inhibition of antidiuretic hormone secretion by ethanol. Volume depletion is a strong stimulus to the sympathetic nervous system and is responsible for elevated cortisol and growth hormone levels.

Dehydration and volume constriction directly decrease the ability of the kidneys to excrete ketoacids. Profound dehydration can culminate in circulatory collapse and/or lactic acidosis.

Fasting

Energy (caloric) restriction secondary to abdominal pain, nausea, or vomiting usually occurs prior to the onset of AKA.[6] Under conditions of starvation, the liver increases the production of ketones from fatty acids to supply the brain, kidney, and other peripheral tissues with a metabolic fuel that can replace glucose. Increased ketogenesis secondary to the utilization of hepatic glycogen stores, with subsequently increased lipolysis and a decreased insulin-to-glucagon ratio, causes starvation ketosis.

Triglycerides stored in adipose tissue undergo lipolysis and are released into the circulation as free fatty acids bound ionically to albumin. Free fatty acids are removed by the liver, where they primarily undergo oxidation to hydroxybutyric acid and acetoacetate and subsequently are reesterified to triglyceride. Decreased insulin and elevated glucagon, cortisol, catecholamine, and growth hormone levels can increase the rate of ketogenesis.

Ketogenesis

Increased availability of free fatty acids, which provide the major substrate for ketone body formation. Low insulin levels and elevated glucagon, catecholamine, growth hormone, and cortisol levels provide a hormonal milieu that inhibits the hepatic metabolism of acetyl-coenzyme A via the citric acid cycle and triglyceride synthesis, resulting in ketogenesis. In AKA, the increased ratio of NADH/NAD+ increases the proportion of beta hydroxybutyrate relative to acetoacetate.[4, 9]

Ketone body clearance is decreased by 2 major mechanisms, as follows:

Elevated cortisol levels can increase fatty acid mobilization and ketogenesis. Growth hormone can enhance precursor fatty acid release and ketogenesis during insulin deficiency. Catecholamines, particularly epinephrine, increase fatty acid release and enhance the rate of hepatic ketogenesis.

Insulin release from the pancreatic beta cells might be abnormally sensitive to catecholamine inhibition. The pivotal variable appears to be a relative deficiency of insulin. Individuals with higher insulin levels are more likely to present with the syndrome of alcohol-induced hypoglycemia without ketoacidosis.[10]

In a Japanese study of 1588 alcoholic men, risk factors for the development of ketosis included ADH1B*1/*1 genotype, whiskey or shochu (distilled alcoholic beverages with no carbohydrates) as the drink of choice, hypoglycemia, lower body mass index, and smoking.[11]

Etiology

Most cases of AKA occur when a person with poor nutritional status due to long-standing alcohol abuse who has been on a drinking binge suddenly decreases energy intake because of abdominal pain, nausea, or vomiting. In addition, AKA is often precipitated by another medical illness such as infection or pancreatitis.

AKA results from the accumulation of the hydroxybutyric acid, and acetoacetic acid (true ketoacid), and acetone.[4, 9] Such accumulation is caused by the complex interaction stemming from alcohol cessation, decreased energy intake, volume depletion, and the metabolic effects of hormonal imbalance.

Epidemiology

The 2015 National Survey on Drug Use and Health (NSDUH) stated that 15.1 million adults aged 18 years or older in the United States (equaling 6.2% of people in this age group) suffer from alcohol use disorder. The rate of US alcohol-related deaths is estimated to be 88,000 people per year.[12]

The prevalence of AKA in a given community correlates with the incidence and distribution of alcohol abuse in that community. No racial or sexual differences in incidence are noted.

Age-related differences in incidence

AKA can occur in adults of any age; however, it most often develops in persons aged 20-60 years who are chronic abusers of alcohol. Rarely, AKA occurs after a binge in persons who are not chronic drinkers. Recently, a case report was published of an 11 year-old boy who presented in AKA after drinking ethanol-based mouthwash.[13]

Prognosis

With timely and aggressive intervention, the prognosis for a patient with AKA is good. The long-term prognosis for the patient is influenced more strongly by recovery from alcoholism.

Mortality and morbidity are rare in uncomplicated AKA. The major cause of morbidity and mortality in AKA is not the acidosis itself but is instead the inadequate treatment of concurrent medical or surgical conditions, such as gastrointestinal bleeding and alcohol withdrawal.[1, 4, 14] Complications occur in less than 20% of patients

Mortality is rare; however, alcoholic ketoacidosis (AKA) has been reported as the cause of death in a number of alcoholics. Markedly elevated beta hydroxybutyric acid could lead to death.[4, 9]

Patient Education

Refer the patient for treatment of chronic alcohol abuse. For patient education information, see the Mental Health and Behavior Center, as well as Alcoholism and Alcohol Intoxication.

History

Patients with alcoholic ketoacidosis (AKA) almost always are alcoholics who, prior to the development of ketoacidosis, have engaged in a period of very heavy drinking, with subsequent abrupt cessation of alcohol consumption 1-2 days before presentation. Such presentations typically result from physical complaints, such as the following:

These symptoms usually are attributed to alcoholic gastritis or pancreatitis.

Example case of alcoholic ketoacidosis: A 35-year-old man who chronically abuses alcohol presents with abdominal pain and intractable emesis for the past 2 days. The pain and emesis developed after 5 days of heavy drinking. Since their onset, he stopped eating and drinking altogether. He complains of epigastric pain that radiates through to his back. He is afebrile, tachycardic, and borderline hypotensive. He is sleepy, but awakens easily to verbal stimuli.

Physical Examination

Generally, the physical findings relate to volume depletion and chronic alcohol abuse. Typical characteristics of the latter may include rhinophyma, tremulousness, hepatosplenomegaly, peripheral neuropathy, gynecomastia, testicular atrophy, and palmar erythema. The patient might be tachycardic, tachypneic, profoundly orthostatic, or frankly hypotensive as a result of dehydration from decreased oral intake, diaphoresis, and vomiting.

The patient's breath may carry the fruity odor of ketosis. Tachypnea in the form of the Kussmaul respiration varieties is usually present when the pH is less than 7.2.[10]

Hypothermia is common in AKA. A fever can be a sign of an underlying infectious process.

Abdominal tenderness consistent with a diagnosis of alcoholic liver disease, pancreatitis, gastritis, or peptic ulcer disease may be found on abdominal examination and may mimic an abdominal emergency. Hemoccult-positive stools may be present.

Mental status may be normal or slightly impaired as a result of derangements in electrolytes or vital signs. Severe obtundation; fixed, dilated pupils; and finally, death may occur.

Complications

Complications associated with AKA include the following:

Approach Considerations

Diagnosis of alcoholic ketoacidosis (AKA) requires arterial blood gas (ABG) measurement and serum chemistry assays. Usual laboratory findings include the following[21] :

Arterial Blood Gas Determination

Arterial blood gas (ABG) measurement may show a low pCO2 level, low bicarbonate level, and normal partial pressure of oxygen (pO2) level. The pattern is consistent with a metabolic acidosis with a respiratory compensation.

Serum pH levels may be misleading because the patient with AKA often has a mixed acid-base disorder. In addition to metabolic acidosis due to ketone formation, a metabolic alkalosis may be present due to vomiting and volume depletion.[6] A respiratory alkalosis may be present secondary to hyperventilation. The possibility of a double or triple acid-base disorder means serum pH levels may be near normal despite a severe acid-base disturbance.

A compensatory respiratory alkalosis alone cannot correct the pH to normal, because the drive for compensation decreases as the pH approaches normality. This implies that a significant noncompensatory metabolic alkalosis also must be present if the pH is near the normal range.

Venous blood gas measurements correlate very well with arterial measurements. One should consider using venous blood gas measurements in lieu of arterial blood gas measurements.[22]

Serum Ketones

All patients with AKA have ketonuria and most have ketonemia. In AKA, the average ratio of hydroxybutyric acid (β–OH) to acetoacetic acid (5:1) tends to be higher than that which occurs in diabetic ketoacidosis (3:1).[4, 9, 17] The nitroprusside reaction (Acetest) may be negative or only weakly positive for serum ketones in AKA because nitroprusside reacts with acetone and acetoacetic acid, but not with β–OH.[4, 23] Direct serum measurements of β–OH should be used when available.

With initial therapy, ketone formation shifts toward the production of acetoacetic acid. Measured ketone levels rise, although β-OH levels decrease.

Glucose

The hallmark of AKA is ketoacidosis without marked hyperglycemia; the serum glucose level may be low, normal, or slightly elevated.[3] This finding can help distinguish AKA from diabetic ketoacidosis (DKA). Serum glucose levels above 300 mg/dL usually indicate DKA, unless AKA has developed in a diabetic patient.[17]

Serum Chemistry

The anion gap is elevated. Lactate levels may be elevated. An elevated lactate level (usually does not exceed 3 mmol/L) may result from dehydration or seizure or could be the direct metabolic effect of alcohol.

Hyponatremia and hypokalemia are common laboratory findings in patients with AKA. Vomiting and extracellular volume depletion may cause hyponatremia. Hypokalemia is often associated with hypomagnesemia.

Hypomagnesemia may be caused by poor nutrition, decreased renal absorption of magnesium, or nasogastric suctioning. Serum magnesium levels are not reliable indicators of total body magnesium stores, however. Due to the linked excretion between potassium and magnesium, the presence of hypokalemia is a strong indicator of hypomagnesemia and can be used as a surrogate test to determine if magnesium replacement is needed.

True hypocalcemia associated with hypomagnesemia may be present. Concomitant pancreatitis also may contribute to true hypocalcemia. Factitious hypocalcemia can result from a markedly decreased serum albumin level following prolonged malnutrition with alcoholism.

Phosphate levels may be low, normal, or elevated. Ethanol-enhanced urinary excretion, emesis, and antacid use may contribute to hypophosphatemia in people who have chronic alcoholism.

Hyperuricemia is commonly observed; it results from decreased renal perfusion, tissue catabolism, competitive inhibition of renal uric acid excretion by ketone bodies, and direct ethanol enhancement of adenine nucleotide degradation. In a study of alcoholic Japanese men aged 40 years or older, Yokoyama et al suggested that the development of hyperuricemia was associated with quicker ethanol and acetaldehyde metabolism by those who had both the ADH1B*2 allele and the ALDH2*1/*1 genotype and with greater levels of ketosis.[24]

Complete Blood Cell Count

Anemia may be present secondary to nutritional deficiencies, alcoholic bone marrow suppression, or GI bleeding. The hematocrit (Hct) may be falsely elevated from hemoconcentration in the presence of intravascular volume depletion. Other findings are a decreased white blood cell (WBC) macrocytosis (mean corpuscular volume [MCV] 100-110 fL). Thrombocytopenia may be present due to chronic liver disease.

Liver and Pancreatic Function Tests

Liver and pancreatic function test results, including hepatic enzymes (eg, serum glutamic-oxaloacetic transaminase [SGOT], lactate dehydrogenase [LDH], alkaline phosphatase), total bilirubin, and pancreatic amylase and lipase levels, may be elevated because of associated illnesses (eg, alcohol-induced hepatitis, pancreatitis).

Alcohol levels

Alcohol level may be low or zero due to anorexia and decreased drinking in the preceding 1-3 days. Blood alcohol levels do not typically change the management of AKA and are therefore not often necessary.

Other Laboratory Findings

Free fatty acid levels are usually markedly elevated, which is secondary to increased lipolysis. Insulin levels are low, glucagon levels are high. Cortisol and catecholamine levels are markedly elevated, and modest elevations of growth hormone are common.

Radiography

Because of the high risk of aspiration pneumonia in people with alcoholism, consider obtaining a chest radiograph. Esophageal rupture may occur with prolonged retching, resulting in pneumomediastinum or in subdiaphragmatic air.

Consider obtaining an urgent abdominal series in patients with significant vomiting and abdominal pain. These symptoms may indicate obstruction, perforation of a viscus, and/or pancreatitis.

Approach Considerations

Treatment of alcoholic ketoacidosis (AKA) is directed toward reversing the 3 major pathophysiologic causes of the syndrome, which are:

This goal can usually be achieved through the administration of dextrose and saline solutions.[4]

Carbohydrate and fluid replacement reverse the pathophysiologic derangements that lead to AKA by increasing serum insulin levels and suppressing the release of glucagon and other counterregulatory hormones. Dextrose stimulates the oxidation of NADH and aids in normalizing the NADH/NAD+ ratio. Fluids alone do not correct AKA as quickly as do fluids and carbohydrates together. Indeed, evidence-based guidelines by Flannery et al, on the management of intensive care unit patients with a chronic alcohol disorder, including symptoms that mimic or mask Wernicke encephalopathy, recommend that in cases of suspected AKA, dextrose-containing fluids be used in place of normal saline during the first day of admission.[25]

In alcoholics, thiamine (100 mg IV or IM) should be administered prior to any glucose-containing solutions. This will decrease the risk of precipitating Wernicke encephalopathy or Korsakoff syndrome.[15]

Phosphate depletion is also common in alcoholics. The plasma phosphate concentration may be normal on admission; however, it typically falls to low levels with therapy as insulin drives phosphate into the cells. When present, severe hypophosphatemia may be associated with marked and possibly life-threatening complications, such as myocardial dysfunction, in these patients.

Institute appropriate treatment for serious, coexisting, acute illnesses. These may include pancreatitis, hepatitis, heart failure, or infection.

Prevention of AKA involves the treatment of chronic alcohol abuse.

Transfer considerations

Patients generally do not need to be transferred to special facilities. Appropriately evaluate the patient for any life-threatening complications before a transfer is considered. Always assess the patient's stability for transfer.

Treatment of Severe Acidosis

Bicarbonate therapy should be considered only in the face of severe, life-threatening acidosis (ie, pH < 7.1) that is unresponsive to fluid therapy.

Management of Alcohol Withdrawal Syndrome

Evaluate the patient for signs of alcohol withdrawal syndrome, which may include the following:

Exclude other causes of autonomic hyperactivity and altered mental status. If the diagnosis of alcohol withdrawal syndrome is established, consider the judicious use of benzodiazepines, which should be titrated to clinical response.

Consultations

The underlying severity of the disease process and of the underlying diseases associated with AKA determines the role of the consultant. Patients with uncomplicated AKA may need nothing more than appropriate treatment and observation until their metabolic and systemic abnormalities are resolved. Patients with an acute abdomen need consultation with a surgeon. Patients with underlying medical problems may need to consult with the appropriate specialist.

If indicated, provide follow-up with AKA patients to assess the problem of alcohol abuse. Consider referral to a counselor at an alcohol treatment center.

Long-Term Monitoring

Arrange follow-up to evaluate patients after the resolution of symptoms, in order to detect other complications of chronic alcohol abuse. The patient may benefit from an alcohol rehabilitation program.

Medication Summary

Potassium repletion is indicated in hypokalemic patients and normokalemic patients with acidemia.

Magnesium repletion is indicated in all patients to help restore calcium and potassium homeostasis and to prevent alcohol withdrawal. Phosphate repletion is recommended only if severe hypophosphatemia is present. Thiamine repletion is indicated routinely to provide prophylaxis against the development of Wernicke encephalopathy.[15]

Potassium acid phosphate (K-Phos)

Clinical Context:  Potassium is essential for transmission of nerve impulses, contraction of cardiac muscle, maintenance of intracellular tonicity and skeletal and smooth muscles, and maintenance of normal renal function. Gradual potassium depletion occurs via renal excretion through GI loss or because of low intake.

Magnesium sulfate

Clinical Context:  Magnesium is a cofactor in enzyme systems involved in neurochemical transmission and muscular excitability.

Potassium phosphate/sodium acid phosphate

Clinical Context:  Response to IV phosphorus supplementation is highly variable and is associated with hyperphosphatemia and hypocalcemia. Base the rate of infusion and the choice of initial dosage on the severity of the hypophosphatemia and on the presence of symptoms. IV preparations are available as sodium or potassium phosphate.

Class Summary

These agents are used to replenish electrolyte levels that have been depleted.

Thiamine (Vitamin B-1)

Clinical Context:  This vitamin is indicated for thiamine deficiency, including Wernicke encephalopathy syndrome.

Class Summary

Vitamins are essential for normal DNA synthesis and cell function.

What is alcoholic ketoacidosis (AKA)?What are the pathophysiologic causes of alcoholic ketoacidosis (AKA)?What is the pathogenesis of alcoholic ketoacidosis (AKA)?What is the pathophysiology of alcoholic ketoacidosis (AKA)?What is the role of ethanol metabolism in alcoholic ketoacidosis (AKA)?What is the role of dehydration in alcoholic ketoacidosis (AKA)?What is the role of fasting in the development of alcoholic ketoacidosis (AKA)?How is ketone body clearance decreased in alcoholic ketoacidosis (AKA)?What is the role of ketogenesis in the development of alcoholic ketoacidosis (AKA)?What causes alcoholic ketoacidosis (AKA)?What is the epidemiology of alcoholic ketoacidosis (AKA)?What is the prognosis of alcoholic ketoacidosis (AKA)?What referral and education should be provided to patients with alcoholic ketoacidosis (AKA)?What are the presenting features of alcoholic ketoacidosis (AKA)?What is the typical presentation of alcoholic ketoacidosis (AKA)?What are the physical findings in alcoholic ketoacidosis (AKA)?What are the complications of alcoholic ketoacidosis (AKA)?What are the diagnostic considerations in alcoholic ketoacidosis (AKA)?Which disorders may be seen in patients with alcoholic ketoacidosis (AKA)?What are the differential diagnoses for Alcoholic Ketoacidosis?What are usual lab findings in alcoholic ketoacidosis (AKA)?What is the role of arterial blood gas (ABG) measurement in the workup of alcoholic ketoacidosis (AKA)?What is the role of a serum ketone test in the workup of alcoholic ketoacidosis (AKA)?What is the role of glucose testing in the workup of alcoholic ketoacidosis (AKA)?What are the serum chemistry findings in alcoholic ketoacidosis (AKA)?What are the CBC findings in the workup of alcoholic ketoacidosis (AKA)?What is the role of liver and pancreatic function tests in the workup of alcoholic ketoacidosis (AKA)?What is the role of blood alcohol measurement in the workup of alcoholic ketoacidosis (AKA)?What are other lab findings in alcoholic ketoacidosis (AKA)?What is the role of imaging studies in the workup of alcoholic ketoacidosis (AKA)?What treatment addresses the pathophysiologic causes of alcoholic ketoacidosis (AKA)?What are the approach considerations in the treatment of alcoholic ketoacidosis (AKA)?When is transfer indicated for patients with alcoholic ketoacidosis (AKA)?When is bicarbonate therapy indicated in the treatment of alcoholic ketoacidosis (AKA)?What are the signs of alcohol withdrawal syndrome?Which specialist consultations are indicated in the treatment of ketoacidosis (AKA)?What follow-up care is indicated in the treatment of alcoholic ketoacidosis (AKA)?Which medications are used in the treatment of alcoholic ketoacidosis (AKA)?Which medications in the drug class Vitamins are used in the treatment of Alcoholic Ketoacidosis?Which medications in the drug class Electrolyte Supplements, Parenteral are used in the treatment of Alcoholic Ketoacidosis?

Author

George Ansstas, MD, Assistant Professor of Medicine, Division of Medical Oncology, Washington University School of Medicine

Disclosure: Nothing to disclose.

Coauthor(s)

David S Schade, MD, Chief, Division of Endocrinology and Metabolism, Professor, Department of Internal Medicine, University of New Mexico School of Medicine and Health Sciences Center

Disclosure: Nothing to disclose.

Irina Robinson, MD, Fellow, Department of Endocrinology and Metabolism, University of New Mexico School of Medicine and Health Sciences Center

Disclosure: Nothing to disclose.

Sofya M Rubinchik, MD, Consulting Staff, Department of Behavioral Health, Lovelace Medical Center

Disclosure: Nothing to disclose.

Specialty Editors

Francisco Talavera, PharmD, PhD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Arthur B Chausmer, MD, PhD, FACP, FACE, FACN, CNS, Professor of Medicine (Endocrinology, Adj), Johns Hopkins School of Medicine; Affiliate Research Professor, Bioinformatics and Computational Biology Program, School of Computational Sciences, George Mason University; Principal, C/A Informatics, LLC

Disclosure: Nothing to disclose.

Chief Editor

Romesh Khardori, MD, PhD, FACP, Professor of Endocrinology, Director of Training Program, Division of Endocrinology, Diabetes and Metabolism, Strelitz Diabetes and Endocrine Disorders Institute, Department of Internal Medicine, Eastern Virginia Medical School

Disclosure: Nothing to disclose.

References

  1. Adams SL. Alcoholic ketoacidosis. Emerg Med Clin North Am. 1990 Nov. 8(4):749-60. [View Abstract]
  2. Harper JP. Alcoholic ketoacidosis. N Z Med J. 1997 Jan 24. 110(1036):18. [View Abstract]
  3. Fulop M. Alcoholic ketoacidosis. Endocrinol Metab Clin North Am. 1993 Jun. 22(2):209-19. [View Abstract]
  4. Palmer JP. Alcoholic ketoacidosis: clinical and laboratory presentation, pathophysiology and treatment. Clin Endocrinol Metab. 1983 Jul. ID - AM17047/AM/NIADDK(2):381-9. [View Abstract]
  5. Al-Sanouri I, Dikin M, Soubani AO. Critical care aspects of alcohol abuse. South Med J. 2005 Mar. 98(3):372-81. [View Abstract]
  6. Wrenn KD, Slovis CM, Minion GE, et al. The syndrome of alcoholic ketoacidosis. Am J Med. 1991 Aug. 91(2):119-28. [View Abstract]
  7. Howard RD, Bokhari SRA. Alcoholic Ketoacidosis (AKA). 2018 Jan. [View Abstract]
  8. Schreiber M, Steele A, Goguen J, et al. Can a severe degree of ketoacidosis develop overnight?. J Am Soc Nephrol. 1996 Feb. 7(2):192-7. [View Abstract]
  9. Iten PX, Meier M. Beta-hydroxybutyric acid -- an indicator for an alcoholic ketoacidosis as cause of death in deceased alcohol abusers. J Forensic Sci. 2000 May. 45(3):624-32. [View Abstract]
  10. Marinella MA. Alcoholic ketoacidosis presenting with extreme hypoglycemia. Am J Emerg Med. 1997 May. 15(3):280-1. [View Abstract]
  11. Yokoyama A, Yokoyama T, Mizukami T, et al. Alcoholic Ketosis: Prevalence, Determinants, and Ketohepatitis in Japanese Alcoholic Men. Alcohol Alcohol. 2014 Nov. 49 (6):618-25. [View Abstract]
  12. Alcohol Facts and Statistics. National Institute on Alcohol Abuse and Alcoholism. Available at https://www.niaaa.nih.gov/alcohol-health/overview-alcohol-consumption/alcohol-facts-and-statistics. Updated 2018 Aug; Accessed: 2018 Oct 7.
  13. Manini AF, Hoffman RS, Nelson LS. Alcoholic ketoacidosis in an 11-year-old boy. Pediatr Emerg Care. 2008 Mar. 24(3):170-1. [View Abstract]
  14. Ngatchu T, Sangwaiya A, Dabiri A, et al. Alcoholic ketoacidosis with multiple complications: a case report. Emerg Med J. 2007 Nov. 24(11):776-7. [View Abstract]
  15. Diltoer MW, Troubleyn J, Lauwers R, et al. Ketosis and cardiac failure: common signs of a single condition. Eur J Emerg Med. 2004 Jun. 11(3):172-5. [View Abstract]
  16. Yanagawa Y, Sakamoto T, Okada Y. Six cases of sudden cardiac arrest in alcoholic ketoacidosis. Intern Med. 2008. 47(2):113-7. [View Abstract]
  17. Umpierrez GE, DiGirolamo M, Tuvlin JA, et al. Differences in metabolic and hormonal milieu in diabetic- and alcohol-induced ketoacidosis. J Crit Care. 2000 Jun. 15(2):52-9. [View Abstract]
  18. Samaha FF, Iqbal N, Seshadri P, et al. A low-carbohydrate as compared with a low-fat diet in severe obesity. N Engl J Med. 2003 May 22. 348(21):2074-81. [View Abstract]
  19. Wootton-Gorges SL, Buonocore MH, Kuppermann N, et al. Cerebral proton magnetic resonance spectroscopy in children with diabetic ketoacidosis. AJNR Am J Neuroradiol. 2007 May. 28(5):895-9. [View Abstract]
  20. Ferreri R. Treatment practices of diabetic ketoacidosis at a large teaching hospital. J Nurs Care Qual. 2008 Apr-Jun. 23(2):147-54. [View Abstract]
  21. Kugelberg FC, Jones AW. Interpreting results of ethanol analysis in postmortem specimens: a review of the literature. Forensic Sci Int. 2007 Jan 5. 165(1):10-29. [View Abstract]
  22. Kelly AM. The case for venous rather than arterial blood gases in diabetic ketoacidosis. Emerg Med Australas. 2006 Feb. 18(1):64-7. [View Abstract]
  23. Pounder DJ, Stevenson RJ, Taylor KK. Alcoholic ketoacidosis at autopsy. J Forensic Sci. 1998 Jul. 43(4):812-6. [View Abstract]
  24. Yokoyama A, Yokoyama T, Mizukami T, et al. Alcohol Dehydrogenase-1B (rs1229984) and Aldehyde Dehydrogenase-2 (rs671) Genotypes and Alcoholic Ketosis Are Associated with the Serum Uric Acid Level in Japanese Alcoholic Men. Alcohol Alcohol. 2016 May. 51 (3):268-74. [View Abstract]
  25. Flannery AH, Adkins DA, Cook AM. Unpeeling the Evidence for the Banana Bag: Evidence-Based Recommendations for the Management of Alcohol-Associated Vitamin and Electrolyte Deficiencies in the ICU. Crit Care Med. 2016 Aug. 44 (8):1545-52. [View Abstract]